FDA-Inspected Site

LeMaitre Vascular, Inc.

12 FDA inspections are on record for LeMaitre Vascular, Inc. in North Brunswick, United States.

483· Form 483 issued

North Brunswick, United States · Last updated August 15, 2026

Overview

  • 12 FDA inspections are on record.
  • 7 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-06-25.

At a glance

Inspections

12

Form 483s

7

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
27 May 2026 – 25 Jun 2026Medical Devices & Rad Health483View 483 →
4 Mar 2025 – 16 Apr 2025Medical Devices & Rad Health483View 483 →
27 Mar 2023 – 13 Apr 2023Medical Devices & Rad Health483View 483 →
13 Feb 2018 – 16 Feb 2018Medical Devices & Rad HealthClean
13 Jan 2015 – 28 Jan 2015Medical Devices & Rad Health483View 483 →
15 Oct 2013 – 22 Oct 2013Medical Devices & Rad HealthClean
25 Jan 2013Not recordedClean
20 Dec 2010Not recorded483View 483 →
8 Mar 2010Not recordedWLView 483 →
24 Jan 2008Not recorded483On file
10 Jun 2003Not recordedClean
8 Dec 2000Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

25 Jun 2026
ISO 13485:2016 Clause 6.4.2

Arrangements for control of contaminated product not planned and documented

Cited by Frank J Marciniak, Matthew W Kyle

25 Jun 2026
ISO 13485:2016 Clause 7.3.3

Design and development inputs do not include all requirements

Cited by Frank J Marciniak, Matthew W Kyle

25 Jun 2026
ISO 13485:2016 Clause 7.5.1

Production and service provision not adequate

Cited by Frank J Marciniak, Matthew W Kyle

25 Jun 2026
ISO 13485:2016 Clause 7.5.11

Procedures for preserving the conformity of product not documented

Cited by Frank J Marciniak, Matthew W Kyle

25 Jun 2026
ISO 13485:2016 Clause 8.2.1

Information gathered in feedback process not used as input into risk management

Cited by Frank J Marciniak, Matthew W Kyle

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.75(a)Cited across public-safe Form 483 observations5x
21 CFR 820.100(a)Cited across public-safe Form 483 observations3x
21 CFR 820.70(c)Cited across public-safe Form 483 observations3x
21 CFR 820.70(e)Cited across public-safe Form 483 observations3x
21 CFR 820.184Cited across public-safe Form 483 observations2x
21 CFR 820.25(b)Cited across public-safe Form 483 observations2x
21 CFR 820.75(b)Cited across public-safe Form 483 observations2x
21 CFR 820.75(c)Cited across public-safe Form 483 observations2x
21 CFR 820.100(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.150(a)Cited across public-safe Form 483 observations1x
21 CFR 820.181Cited across public-safe Form 483 observations1x
21 CFR 820.250(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x
21 CFR 820.70(g)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.90(a)Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 6.4.2Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.3.3Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.5.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.5.11Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.2.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.3.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.5.2Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.5.3Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind LeMaitre Vascular, Inc.'s 7 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat